z-logo
open-access-imgOpen Access
Dacomitinib improves chemosensitivity of cisplatin‑resistant human ovarian cancer cells
Author(s) -
Lei Xu,
Ying Xu,
Jianbing Zheng,
Yun Zhao,
Hongcai Wang,
Yushu Qi
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12830
Subject(s) - cisplatin , paclitaxel , ovarian cancer , pharmacology , cell cycle , cancer research , epidermal growth factor receptor , apoptosis , cancer , viability assay , cancer cell , oncogene , medicine , chemistry , chemotherapy , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom